GGrantIndex
← Leaderboards

Christoph Hornik

Duke University

$12,153,670
Attributed
$22,636,617
Total exposure
12
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.2M · FY201725
$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,636,617 · 11
FDA$2,000,000 · 1

By mechanism

OT2$6,823,028 · 1
R33$6,819,944 · 1
U01$2,213,145 · 1
U18$2,000,000 · 1
R01$1,830,595 · 1
RL1$793,357 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Public Health

Research focus

Public HealthPharmaceutical PreparationsChildhoodNational Institute Of Child Health And Human DevelopmentRecording Of Previous EventsFundingClinical TrialsCollaborationsAreaInfantResponseScienceResearch InstituteMortalityClinical ResearchAffectChildMorbidity - Disease RateDoctor Of PhilosophyInnovationEnsureSuccessEnrollmentParticipant

Grant awards (31)

Collaborative Pediatric Critical Care Research Network - Clinical Site$158,514
RL1 · FY2025 · HD · contact PI
Mentoring in Pediatric Cardiovascular Pharmacology and Early Phase Trials$121,059
K24 · FY2025 · HL · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$91,926
PL1 · FY2025 · HD · contact PI
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease$629,432
R01 · FY2024 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$156,929
RL1 · FY2024 · HD · contact PI
Mentoring in Pediatric Cardiovascular Pharmacology and Early Phase Trials$121,059
K24 · FY2024 · HL · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$88,219
PL1 · FY2024 · HD · contact PI
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia$2,186,920
R33 · FY2023 · HL · contact PI
Duke HEAL R-DEC$1,810,932
OT2 · FY2023 · OD · contact PI
You and Me Healthy: Testing Protocol$1,116,426
U01 · FY2023 · MD · contact PI
You and Me Healthy: Testing Protocol$1,096,719
U01 · FY2023 · MD · contact PI
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease$551,975
R01 · FY2023 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$158,517
RL1 · FY2023 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$83,192
PL1 · FY2023 · HD · contact PI
Duke HEAL R-DEC$5,012,096
OT2 · FY2022 · OD · contact PI
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia$2,307,686
R33 · FY2022 · HL · contact PI
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease$649,188
R01 · FY2022 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$158,397
RL1 · FY2022 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$83,130
PL1 · FY2022 · HD · contact PI
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia$2,325,338
R33 · FY2021 · HL · contact PI
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2021 · FD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$161,000
RL1 · FY2021 · HD · contact PI
Collaborative Pediatric Critical Care Research Network - Clinical Site$86,694
PL1 · FY2021 · HD · contact PI
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2020 · FD · contact PI
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia$362,871
R61 · FY2020 · HL · contact PI
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass$161,389
K23 · FY2020 · HD · contact PI
Pediatric Critical Care Research Landscape - A National Expert Conference$60,285
R13 · FY2020 · HD · contact PI
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia$412,278
R61 · FY2019 · HL · contact PI
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass$161,482
K23 · FY2019 · HD · contact PI
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass$161,482
K23 · FY2018 · HD · contact PI
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass$161,482
K23 · FY2017 · HD · contact PI